Regorafenib in previously treated metastatic colorectal cancer (mCRC): Analysis of age subgroups in the open-label phase 3b CONSIGN trial
Journal article published in 2016 by
F. Ciardiello,
L. Salvatore 
,
S. Cascinu,
A. Sobrero,
C. Banzi,
C. Barone,
A. Spallanzani,
T. P. Latiano,
S. Siena,
F. Bergamo,
G. Cartenì,
F. Di Costanzo,
M. Di Bartolomeo,
A. Santoro ,
A. Russo
and other authors.
,
S. Cascinu,
A. Sobrero,
C. Banzi,
C. Barone,
A. Spallanzani,
T. P. Latiano,
S. Siena,
F. Bergamo,
G. Cartenì,
F. Di Costanzo,
M. Di Bartolomeo,
A. Santoro ,
A. Russo
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 